PCORnet Opioid Surveillance Study

Status Completed

Clinical Trial Summary

The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, processes, and outcomes related to opioid use, misuse, and abuse. It will quantify the utility of data stored in the PCORnet Common Data Model format stewarded by healthcare organizations participating in PCORnet.

Clinical Trial Description

This is a two phase retrospective study. The goal of Phase I is to assess the utility of PCORnet Common Data Mode (CDM) data to study risk factors, processes, and outcomes related to opioid use, misuse, and abuse. Based on the results of the Phase I feasibility examination, Phase II will be conducted and will analyze the relationships between patient- and provider-level risk factors and policies, and opioid-related outcomes over time and within geographic regions. The study will leverage the existing data PCORnet data infrastructure and resources to achieve its objectives and answer its research questions. Standardized analysis programs will be distributed to participating sites within the PCORnet Distributed Research Network. Sites will return aggregate, descriptive counts and summary statistics from regression analyses. When data are unavailable or analysis is determined infeasible, results will be reported as such. The Aims of Phase I are: 1. Generate counts and proportion of patients with exposure (or potential exposure) to opioids though prescription or dispensing records within a health system. a. Compare results to CDC. 2. Characterize data elements in PCORnet data and assess suitability for opioid surveillance. 1. Identify the relevant data elements 2. Examine data completeness and validity 3. Identify data limitations and gaps that limit surveillance The Aims of Phase II are: 1. Examine whether and to what extent patient-level risk factors, provider processes, and policies are associated with declines in outcomes of interest. 2. Examine whether and to what extent prescribing guidelines, related policies, processes, and/or care procedures are associated opioid-related outcomes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03743493
Study type	Observational
Source	Louisiana Public Health Institute
Contact
Status	Completed
Phase
Start date	July 1, 2018
Completion date	November 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04095624` - Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion	N/A
Completed	`NCT04484610` - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study	Phase 4
Recruiting	`NCT04598074` - Opioid Package Prototype (OPP)	N/A
Recruiting	`NCT06033599` - Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement	Phase 3
Recruiting	`NCT06032559` - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment	Phase 3
Completed	`NCT05845177` - Persistent Pain After Hip Replacement
Completed	`NCT03268551` - MEMO-Medical Marijuana and Opioids Study
Completed	`NCT03570320` - Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?	N/A
Completed	`NCT04526236` - Influence of Aging on Perioperative Methadone Dosing	Phase 4
Completed	`NCT05593341` - Opioid Education in Total Knee Arthroplasty	N/A
Recruiting	`NCT06055205` - A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries	N/A
Recruiting	`NCT05877157` - Pain AND Opioids After Surgery
Recruiting	`NCT03675386` - Reducing Opioid Use for Chronic Pain Patients Following Surgery	N/A
Suspended	`NCT05001789` - Cognitive Functioning in Opioid Use Disorder	N/A
Completed	`NCT04296396` - Opioid Prescription After Cesarean Trial	Phase 3
Not yet recruiting	`NCT04868552` - Naloxone Education in Total Joint Patients	N/A
Completed	`NCT03540030` - Opioid-Free Shoulder Arthroplasty	Phase 4
Terminated	`NCT06217380` - Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program	N/A
Recruiting	`NCT05976646` - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion	Phase 1/Phase 2
Completed	`NCT03472521` - Prevention of Persistent Opioid Use in Mothers	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.